Cardiovascular disease still remains the
leading cause of death.
CRC offers innovative access to the patients, providers, and the evidence to advance the understanding of heart disease
Real Answers on Heart Disease Requires Real World Data
Claims Data verses EMR Data
The biomedical sciences industry has relied on clinical trial and claims data for years to drive improvements in heart care. Conventional claims data is based on billing codes utilized by providers for optimal reimbursements. Trial data is often limited in its scope. The true data lies in the clinical data captured in the patients’ electronic medical records. However, the real world data in EMRs has been difficult to access, aggregate, and analyze, especially at a large enough scale to provide statistically significant answers. That is until now.
Community-based Cardiology Practices
The first of its kind, the Cardiovascular Research Consortium provides cardiac drug and device manufactures, and other cardiovascular research stakeholders, with a diverse and national pool of research-experienced cardiologists…each utilizing a single EMR platform to provide access to one
of the largest searchable cardiology patient bases in the US.
A Cardiac Patient Population in the Millions…and Growing
Acute Myocardial Infarction
Angina/Cardiac Ischemias
Arrhythmias/Atrial Fibrillation
Cardiomyopathy
Chronic Stable Angina Picturis
Congestive Heart Failure (CHF)
Coronary Artery Disease (CAD)/Arteriosclerosis
Diagnostic Testing/Devices
Dyslipidemias
Hypercholesterolemia
Hypertension (High Blood Pressure)
Orthostatic Hypotension
Pacemakers
Percutaneous Transluminal Coronary Angioplasty (PTCA)
Prinzmetal Angina